Fig. 1From: First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patientsFinal refined tertiary structures for NS5A and NS5B proteins by I-TASSER and evaluated by 4 online programs. Results indicated significant differences between 1 and 3a genotypesBack to article page